DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Clinical practice gaps and challenges in non‐alcoholic steatohepatitis care: An international physician needs assessment

Journal Article · · Liver International
DOI: https://doi.org/10.1111/liv.15324 · OSTI ID:1871849
ORCiD logo [1];  [2];  [3];  [4];  [5];  [6];  [1]
  1. AXDEV Group Inc. Québec Canada
  2. Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM) and NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital Headington UK
  3. Liver Institute Northwest and Washington State University Seattle WA USA
  4. Università degli Studi di Milano Milano Italy, IRCCS MultiMedica Milan Italy, International Atherosclerosis Society Milan Italy
  5. International Atherosclerosis Society Milan Italy, Heart Institute (InCor) University of São Paulo Medical School Hospital São Paulo Brazil, Hospital Israelita Albert Einstein São Paulo Brazil
  6. AXDEV Global Inc. Virginia Beach Virginia USA

Abstract Background and aims Even as several pharmacological treatments for non‐alcoholic steatohepatitis (NASH) are in development, the incidence of NASH is increasing on an international scale. We aim to assess clinical practice gaps and challenges of hepatologists and endocrinologists when managing patients with NASH in four countries (Germany/Italy/United Kingdom/United States) to inform educational interventions. Methods A sequential mixed‐method design was used: qualitative semi‐structured interviews followed by quantitative online surveys. Participants were hepatologists and endocrinologists practising in one of the targeted countries. Interview data underwent thematic analysis and survey data were analysed with chi‐square and Kruskal‐Wallis tests. Results Most interviewees ( n  = 24) and surveyed participants (89% of n  = 224) agreed that primary care must be involved in screening for NASH, yet many faced challenges involving and collaborating with them. Endocrinologists reported low knowledge of which blood markers to use when suspecting NASH (56%), when to order an MRI (65%) or ultrasound/FibroScan® (46%), and reported sub‐optimal skills interpreting alanine aminotransferase (ALT, 37%) and aspartate aminotransferase (AST, 38%) blood marker test results, causing difficulty during diagnosis. Participants believed that more evidence is needed for upcoming therapeutic agents; yet, they reported sub‐optimal knowledge of eligibility criteria for clinical trials. Knowledge and skill gaps when managing comorbidities, as well as skill gaps facilitating patient lifestyle changes were reported. Conclusions Educational interventions are needed to address the knowledge and skill gaps identified and to develop strategies to optimize patient care, which include implementing relevant care pathways, encouraging referrals and testing, and multidisciplinary collaboration, as suggested by the recent Global Consensus statement on NAFLD.

Sponsoring Organization:
USDOE
OSTI ID:
1871849
Journal Information:
Liver International, Journal Name: Liver International Journal Issue: 8 Vol. 42; ISSN 1478-3223
Publisher:
Wiley-BlackwellCopyright Statement
Country of Publication:
United Kingdom
Language:
English

References (43)

Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: Diagnostic Challenges of NAFLD/NASH journal April 2018
NASH: Connecting the dots with patients in mind journal October 2020
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases: Hepatology, Vol. XX, No. X, 2017 journal September 2017
NASH-related cirrhosis: An occult liver disease burden: Arrese and Feldstein journal April 2017
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists journal July 2020
Unmasking a Stealth Killer: The Need for Increased Awareness of NASH journal September 2019
Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study journal December 2018
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management journal April 2021
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality journal January 2022
Horizon scanning of therapeutic modalities for nonalcoholic steatohepatitis journal September 2021
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps journal March 2019
Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice journal December 2017
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis journal February 2018
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions journal May 2017
Challenges and opportunities in drug development for nonalcoholic steatohepatitis journal March 2020
Current efforts and trends in the treatment of NASH journal April 2015
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis journal October 2019
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update journal September 2021
Lifestyle modification in NAFLD/NASH: Facts and figures journal December 2019
Nonalcoholic Fatty Liver Disease: Evidence-Based Management and Early Recognition of Nonalcoholic Steatohepatitis journal October 2019
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease journal July 2021
Defining comprehensive models of care for NAFLD journal June 2021
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis journal March 2021
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease journal October 2021
Nonalcoholic Fatty Liver Disease: A Silent Epidemic journal January 2019
Current management of NAFLD/NASH journal June 2021
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health journal April 2019
NAFLD: a multisystem disease that requires a multidisciplinary approach journal May 2019
Differential payment to research participants in the same study: an ethical analysis journal March 2019
Mixed Methods in Biomedical and Health Services Research journal January 2013
Three Approaches to Qualitative Content Analysis journal November 2005
Research Design for Mixed Methods: A Triangulation-based Framework and Roadmap journal July 2016
Mixed Research as a Tool for Developing Quantitative Instruments journal December 2009
Thematic Analysis: Striving to Meet the Trustworthiness Criteria journal July 2017
Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists journal March 2016
A Disconnect Between Clinical Practice and Practice Guidelines in the Diagnosis and Evaluation of NASH: Another Factor Limiting Access to Care: 2225 journal January 2015
Sampling: how to select participants in my research study? journal June 2016
Noninvasive Diagnosis of NAFLD and NASH journal April 2020
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis journal January 2015
Current status, problems, and perspectives of non-alcoholic fatty liver disease research journal January 2019
Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns journal January 2018
Treatment of Fatty Liver Disease: The Present and the Future journal January 2021
Lifestyle Medicine: A Brief Review of Its Dramatic Impact on Health and Survival journal March 2018